Bai, J.Nguyen, DuyFaunce, Thomas2015-12-101741-1343http://hdl.handle.net/1885/51254The Australia-United States Free Trade Agreement (AUSFTA) came into force on 1 January 2005. Before and subsequently to the AUSFTA being concluded, controversy surrounded the debate over its impact on Australia's health policy, specifically on regulationKeywords: atorvastatin; bromocriptine; etiracetam; generic drug; lamotrigine; olanzapine; pramipexole; quetiapine; risperidone; rosuvastatin; Australia; Australia United States Free Trade Agreement; competition; cost effectiveness analysis; cost minimization analys Data exclusivity; Evergreening; Innovation; Pharmaceutical benefi ts scheme; Reference pricing; Trade agreement201010.1057/jgm.2009.402016-02-24